Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hemangiosarcoma × avelumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Transitional Cell 12 Urinary Bladder Neoplasms 11 Colorectal Neoplasms 10 Carcinoma, Merkel Cell 9 Breast Neoplasms 9 Neoplasms 6 Neoplasm Metastasis 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Small Cell Lung Carcinoma 4 Carcinoma, Hepatocellular 4 Turcot syndrome 3 Stomach Neoplasms 3 Neuroendocrine Tumors 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Penile Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Melanoma 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Neuroendocrine 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thymoma 1

Interventions

Paclitaxel 5 Doxorubicin 5 Gemcitabine 4 pembrolizumab 3 pazopanib 3 durvalumab 3 Sorafenib 3 Docetaxel 3 trebananib 2 spartalizumab 2 brostallicin 2 Propranolol 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 Imatinib Mesylate 2 Carboplatin 2 Bevacizumab 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 tremelimumab 1 trastuzumab duocarmazine 1 temsirolimus 1 talazoparib 1 soblidotin 1 sintilimab 1 sarilumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03512834 2018-07-11

ASAP

Dong-A University Hospital

Phase 2 Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡